Sun Hai-Lu, Zhao Xiang-Yu, Mo Xiao-Dong, Lv Meng, Sun Yu-Qian, Wei Fang-Fang, Xu Lan-Ping, Wang Yu, Zhang Xiao-Hui, Huang Xiao-Jun, Zhao Xiao-Su, Pei Xu-Ying
Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
Peking-Tsinghua Center for Life Sciences, Beijing, China.
Front Med (Lausanne). 2025 Aug 7;12:1638865. doi: 10.3389/fmed.2025.1638865. eCollection 2025.
Viral enteritis is a common complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, data regarding the most frequent enteric pathogens, clinical characteristics, and patient outcomes remains limited. To better characterize post-HSCT viral enteritis, we retrospectively analyzed 59 patients who underwent allo-HSCT and were diagnosised with viral enteritis based on intestinal biopsy specimens. The most frequently identified pathogens were cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), and Epstein-Barr virus (EBV), accounting for 37.3%, 37.3%, and 33.9% of cases, respectively. The median time for diagnosis was 56 days post-allo-HSCT. Diarrhea and abdominal pain were the predominant symptoms. Notably, 35 patients experienced diarrhea lasting 14 days or more, with a median duration of 16 days (range: 3-57 days). Forty-five patients were diagnosed with concurrent graft-versus-host disease (GVHD) by endoscopic examination. The overall survival rates for patients with viral enteritis at 1 and 3 years were 68.7% and 58.1%, respectively. Importantly, patients with CMV enteritis had significantly poorer overall survival compared to those with other viral enteritis types ( = 0.035). In conclusion, viral enteritis is a significant complication following allo-HSCT, with CMV, HHV-6, and EBV being the most common pathogens. Early identification and management are crucial, especially for CMV enteritis which is associated with poorer outcomes.
病毒性肠炎是异基因造血干细胞移植(allo-HSCT)后的常见并发症。然而,关于最常见的肠道病原体、临床特征和患者预后的数据仍然有限。为了更好地描述HSCT后病毒性肠炎的特征,我们回顾性分析了59例接受allo-HSCT并根据肠道活检标本诊断为病毒性肠炎的患者。最常鉴定出的病原体是巨细胞病毒(CMV)、人类疱疹病毒6型(HHV-6)和爱泼斯坦-巴尔病毒(EBV),分别占病例的37.3%、37.3%和33.9%。诊断的中位时间为allo-HSCT后56天。腹泻和腹痛是主要症状。值得注意的是,35例患者腹泻持续14天或更长时间,中位持续时间为16天(范围:3-57天)。45例患者通过内镜检查诊断为并发移植物抗宿主病(GVHD)。病毒性肠炎患者1年和3年的总生存率分别为68.7%和58.1%。重要的是,与其他类型的病毒性肠炎患者相比,CMV肠炎患者的总生存率明显较差(=0.035)。总之,病毒性肠炎是allo-HSCT后的一种重要并发症,CMV、HHV-6和EBV是最常见的病原体。早期识别和管理至关重要,尤其是对于预后较差的CMV肠炎。